The opportunity is simple.
Lactate monitoring without needles, without consumables and in real time. A capability athletes have never had in training, and clinicians have never had at the bedside. It's a step change in how the body is monitored, understood and supported.

If you want to shape the future of wearables, performance tech or clinical monitoring, this is the moment to explore what a partnership can unlock.

With over 100 million people across the US, UK, and EU alone wanting continuous lactate monitoring, our breakthrough solution is clearly positioned to answer this demand.

100% non-invasive
This is the first non-invasive technology to deliver continuous biological insight with real accuracy, opening doors for partners who want to lead rather than follow.

Multi-analyte potential
Lactate now; Glucose soon, Oestrogen and Progesterone to followSentinel's technology has been designed to be a multi-analyte monitoring platform. Non-invasive Continuous Lactate Monitoring is validated and ready for commercialisation, blood glucose is in the test phase, whilst Oestrogen and Progesterone will follow for the female fertility market.

Integration with existing tech
We've built a platform that naturally integrates with consumer wearables, elite performance systems, and critical care environments. The data is live, proven and ready for integration. Giving manufacturers a chance to create products that stand out in a crowded marketplace and giving investors a chance to back the shift that will define the next wave of health technology.